Literature DB >> 12876215

Endothelial inflammation: the role of differential expression of N-deacetylase/N-sulphotransferase enzymes in alteration of the immunological properties of heparan sulphate.

Noel M Carter1, Simi Ali, John A Kirby.   

Abstract

Heparan sulphate N-deacetylase/N-sulphotransferase (NDST) enzymes catalyse the reaction that initiates sulphation and subsequent modification of the oligosaccharide, heparan sulphate (HS). The extent and distribution of sulphate substitution on HS plays a vital role in regulation of the binding of a range of proteins, including IFN-gamma, several interleukins and most chemokines. In this study, the expression of NDST transcripts was found to be non-uniform between a range of cell types, suggesting that different cells produce characteristic HS species. It was found that stimulation of the HMEC-1 microvascular endothelial cell line with the pro-inflammatory cytokines IFN-gamma and TNF-alpha caused a transient decrease in the level of NDST-1 and -2 transcripts after 4 hours (P < 0.05 and P < 0.01 respectively), but the expression of NDST-1 increased above control levels after 16 hours (P < 0.01). The change in NDST expression was concurrent with an increase in the abundance of sulphated HS epitopes on the cell surface; this was not caused by variation in the expression of proteoglycans or by changes in the rate of GAG turnover. Cytokine-stimulated endothelial cells also showed an increase in their potential to bind RANTES (CCL5); this was abrogated by chlorate blockade of sulphotransferase activity or by heparitinase cleavage of cell surface HS. Monolayers of cytokine-stimulated HMEC-1 also supported an enhanced leukocyte chemotactic response towards RANTES. This study demonstrated that pro-inflammatory cytokines can increase NDST expression leading to increased sulphation of HS and a corresponding increase in sequestration of functional RANTES at the apical surface of endothelial cells. This may enhance leukocyte extravasation at sites of inflammation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12876215     DOI: 10.1242/jcs.00662

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  19 in total

1.  Heparan Sulfate Regrowth Profiles Under Laminar Shear Flow Following Enzymatic Degradation.

Authors:  Kristina M Giantsos-Adams; Andrew Jia-An Koo; Sukhyun Song; Jiro Sakai; Jagadish Sankaran; Jennifer H Shin; Guillermo Garcia-Cardena; C Forbes Dewey
Journal:  Cell Mol Bioeng       Date:  2013-02-20       Impact factor: 2.321

2.  Regulation of eosinophil recruitment and allergic airway inflammation by heparan sulfate proteoglycan (HSPG) modifying enzymes.

Authors:  Xiao Na Ge; Idil Bastan; Sung Gil Ha; Yana G Greenberg; Jeffrey D Esko; Savita P Rao; P Sriramarao
Journal:  Exp Lung Res       Date:  2018-04-05       Impact factor: 2.459

3.  Method development and analysis of free HS and HS in proteoglycans from pre- and postmenopausal women: evidence for biosynthetic pathway changes in sulfotransferase and sulfatase enzymes.

Authors:  Wei Wei; Rebecca L Miller; Julie A Leary
Journal:  Anal Chem       Date:  2013-05-28       Impact factor: 6.986

4.  Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells.

Authors:  Kathryn S Jones; Cari Petrow-Sadowski; Daniel C Bertolette; Ying Huang; Francis W Ruscetti
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  A 3-O-sulfated heparan sulfate binding peptide preferentially targets herpes simplex virus 2-infected cells.

Authors:  Mohamed M Ali; Ghadah A Karasneh; Min Jung Jarding; Vaibhav Tiwari; Deepak Shukla
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

6.  A comprehensive compositional analysis of heparin/heparan sulfate-derived disaccharides from human serum.

Authors:  Wei Wei; Milady R Niñonuevo; Anish Sharma; Lieza M Danan-Leon; Julie A Leary
Journal:  Anal Chem       Date:  2011-04-19       Impact factor: 6.986

7.  Is human placenta proteoglycan remodeling involved in pre-eclampsia?

Authors:  Mohamad Warda; Fuming Zhang; Moustafa Radwan; Zhenqing Zhang; Nari Kim; Young Nam Kim; Robert J Linhardt; Jin Han
Journal:  Glycoconj J       Date:  2007-12-27       Impact factor: 2.916

Review 8.  Therapeutically targeting protein-glycan interactions.

Authors:  A Rek; E Krenn; A J Kungl
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

Review 9.  Effect of Polarization and Chronic Inflammation on Macrophage Expression of Heparan Sulfate Proteoglycans and Biosynthesis Enzymes.

Authors:  Maarten Swart; Linda Troeberg
Journal:  J Histochem Cytochem       Date:  2018-09-11       Impact factor: 2.479

10.  T cell extravasation: demonstration of synergy between activation of CXCR3 and the T cell receptor.

Authors:  Peter Newton; Graeme O'Boyle; Yvonne Jenkins; Simi Ali; John A Kirby
Journal:  Mol Immunol       Date:  2009-09-20       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.